Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ghigo

Showing results (161-170 of 455) with videos related to

Pageof 46
Sort By:
European Journal of Endocrinology|November 18, 2000
Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving ratsL M Seoane, S Tovar, R Baldelli, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarismM Maghnie, B Salati, S Bianchi, et al.
Journal of Endocrinological Investigation|January 2, 2003
H9c2 cardiac muscle cells express insulin-like growth factor binding protein-3 (IGFBP-3)R Granata, C Gauna, E Arnolfo, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 24, 1997
The GH-releasing effect of Hexarelin, a synthetic hexapeptide, in newborns is lower than in young adultsE Bartolotta, J Bellone, G Aimaretti, et al.
Journal of Thrombosis and Haemostasis : JTH|March 29, 2007
Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanismsR Granata, L Trovato, E Lupia, et al.
Drugs|February 1, 1991
Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implicationsE E Müller, V Locatelli, E Ghigo, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndromeE Ghigo, E Arvat, J Ramunni, et al.
Panminerva Medica|July 1, 1987
Pituitary computed tomography and dynamic tests of prolactin and thyrotropin secretion in 103 hyperprolactinemic patientsE Ciccarelli, E Ghigo, E Mazza, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1990
Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in manE Ghigo, S Goffi, M Nicolosi, et al.
Journal of Endocrinological Investigation|January 31, 2022
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance testF Bioletto, N Prencipe, A M Berton, et al.
Pageof 46

Showing results (161-170 of 455) with videos related to

Sort By:
Pageof 46
European Journal of Endocrinology|November 18, 2000
Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving ratsL M Seoane, S Tovar, R Baldelli, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarismM Maghnie, B Salati, S Bianchi, et al.
Journal of Endocrinological Investigation|January 2, 2003
H9c2 cardiac muscle cells express insulin-like growth factor binding protein-3 (IGFBP-3)R Granata, C Gauna, E Arnolfo, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 24, 1997
The GH-releasing effect of Hexarelin, a synthetic hexapeptide, in newborns is lower than in young adultsE Bartolotta, J Bellone, G Aimaretti, et al.
Journal of Thrombosis and Haemostasis : JTH|March 29, 2007
Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanismsR Granata, L Trovato, E Lupia, et al.
Drugs|February 1, 1991
Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implicationsE E Müller, V Locatelli, E Ghigo, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndromeE Ghigo, E Arvat, J Ramunni, et al.
Panminerva Medica|July 1, 1987
Pituitary computed tomography and dynamic tests of prolactin and thyrotropin secretion in 103 hyperprolactinemic patientsE Ciccarelli, E Ghigo, E Mazza, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1990
Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in manE Ghigo, S Goffi, M Nicolosi, et al.
Journal of Endocrinological Investigation|January 31, 2022
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance testF Bioletto, N Prencipe, A M Berton, et al.
Pageof 46